Denali Therapeutics Inc (DNLI)
SG&A Expenses
$139.03M
TTM · Period ending: · USD
DNLI SG&A Expenses
Latest reported$139.03Mperiod ending
Latest reported$139.03Mperiod ending
DNLI TTM SG&A Expenses ($11.73M → $139.03M)
TTM SG&A Expenses
High-resolution chart · PNG
DNLI sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 139,027,000 | |
| 135,011,000 | |
| 133,698,000 | |
| 127,163,000 | |
| 116,628,000 | |
| 109,555,000 | |
| 105,438,000 | |
| 100,148,000 | |
| 100,524,000 | |
| 101,450,000 | |
| 103,354,000 | |
| 102,101,000 | |
| 100,035,000 | |
| 95,074,000 | |
| 90,475,000 | |
| 88,718,000 | |
| 84,778,000 | |
| 82,664,000 | |
| 79,059,000 | |
| 75,294,000 | |
| 71,780,000 | |
| 66,707,000 | |
| 60,326,000 | |
| 53,211,000 | |
| 48,621,000 | |
| 49,725,000 | |
| 46,480,000 | |
| 46,646,000 | |
| 44,269,000 | |
| 36,089,000 | |
| 32,349,000 | |
| 26,373,000 | |
| 21,308,000 | |
| 17,976,000 | |
| 15,680,000 | |
| 13,657,000 | |
| 12,997,000 | |
| 12,219,000 | |
| 11,731,000 |